Shorted at the open - was going to open at .0410 x
Shorted at the open - was going to open at .0410 x .0421
Hit any ask you like the look of for trading in future - expect a surge up later today as usual - or Friday/Monday in extreme
Groups of amateurs on Reddit - just like in 2021 - want in but currently unable to with the broker they have.
American Fusion Inc (AMFN) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Seismic Shift in Maritime Solutions Alfa Laval's decision to acquire NAVTOR for a massive $700 million in cash throws down a marker in the maritime domain. This isn't some casual, "let's test the waters" thing; it's the kind of big-money play we all sit up and notice. You're talking about Alfa Laval trying to mold the digital side of their maritime offerings, right...
Continue Reading
Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...
Continue Reading
Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....
Continue Reading
Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...
Continue Reading
MNTN's Recent Earnings Call Sparks Controversy Alright, we're back at that crossroads where the rubber meets the road for MNTN's investors. After certain company revelations, folks are wondering what's in the pipeline and how deep this muck goes. Seems like some proverbial skeletons just can't stay in the closet. Dissecting the Earnings Disappointment Here's the scoop:...
Continue Reading
Spotting Bogus Bargains: A Seasonal Security Challenge Here's a festive headache for ya: fake holiday web shops are popping up like those glittery snow globes at a dollar store. Just as holiday shoppers gear up for Black Friday on November 27, there's a troubling fivefold increase in these phony online shops reported over a couple of short months. This isn't just a...
Continue Reading
California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...
Continue Reading
The Power of Building a Legacy There I was, watching the home the VFW built not just with nails and beams, but conviction. In a world where construction and legacy often don't speak the same language, the Frederick VFW Post 3285 is flipping the script. We're looking at a story about real, tangible impact—not in the P&Ls but in actual lives. Brick by Brick: A...
Continue Reading
Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...
Continue Reading
Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...
Continue Reading
Top 5 Most Recently Viewed Articles
Key Financial Dates for 2025 Ringkjøbing Landbobank is gearing up for an important year in 2025, with its financial calendar clearly laid out. It's essential for both shareholders and stakeholders to be aware of these upcoming events, as this knowledge enables active participation in the bank's development and strategic decisions. Essential Dates in the Financial...
Continue Reading
Introduction: The Promise of U.S. Agriculture A recent peer-reviewed report highlights the critical role that U.S. agriculture could play in addressing climate change. With the right conservation practices and modern technologies, agriculture not only has the potential to become greenhouse gas negative but can also improve farmer profitability and resiliency. This...
Continue Reading
Noblestitch™ System Achieves Outstanding Stroke Prevention A pivotal study led by Professor Dr. Achille Gaspardone unveiled remarkable findings about the Noblestitch™ suture-mediated Patent Foramen Ovale (PFO) closure system. The findings were shared at the TCT Congress, showcasing an impressive record of preventing recurrent strokes among patients with histories of...
Continue Reading
Blueprint Medicines: Pioneering Advances in Mast Cell Disorders Blueprint Medicines Corporation (NASDAQ: BPMC) has made remarkable strides in the biopharmaceutical realm, particularly with its flagship drug, AYVAKIT (avapritinib). In 2024, the company generated substantial global net revenues of $479 million from AYVAKIT, which alone accounted for $144 million in the last...
Continue Reading
Point32Health's Exciting New Leadership Announcement Point32Health has made an important advancement by appointing Patrick Gilligan as the new chief executive officer. This announcement, made by the governing board, marks a significant moment for the organization, which includes Harvard Pilgrim Health Care and Tufts Health Plan. Transition to New Leadership The board's...
Continue Reading